Lucie Joerg

Ms. Lucie Joerg

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
LJLucie Joerg
Lucie Joerg
MKMargaret Kabakova
Margaret Kabakova
JWJennifer Y. Wang
Jennifer Y. Wang
EAEvan Austin
Evan Austin
MCMarc Cohen
Marc Cohen
JJJared Jagdeo
Jared Jagdeo

31 July 2025 in Dermato
Verified
Journal Article
Open access
PDF file
ASAlana Sadur
Alana Sadur
LJLucie Joerg
Lucie Joerg
ADAmelia Grace Stapleton Van Doren
Amelia Grace Stapleton Van Doren
ELEllen Tse-Yi Lee
Ellen Tse-Yi Lee
DSDia Shah
Dia Shah
SCSonal Choudhary
Sonal Choudhary
Sleep is crucial to overall health and plays a significant role in skin function. While the circadian rhythm has been extensively researched for its impact on the body’s optimal functioning, the skin also possesses an independent circadian system that serves many important functions. Sleep disruptions or deprivation can significantly affect skin conditions, by compromising the skin barrier and impairing processes such as collagen production, cellular repair, and wound healing. Given the commonality of sleep disturbances, it is crucial to understand the connection between sleep, circadian regulation, and skin health. This is particularly important in understudied populations, such as those with occupational sleep disruption and individuals with hormone-related conditions like PCOS and menopause. Bidirectional relationships have been established between sleep and several inflammatory skin conditions, including atopic dermatitis, psoriasis, rosacea, and hidradenitis suppurativa. While acne is influenced by sleep, the reverse relationship, how acne affects sleep quality, has not been well established. Chronic sleep disruption can increase cortisol levels and oxidative stress, both of which contribute to skin aging and the progression of autoimmune skin conditions, including systemic lupus erythematosus. As sleep is a modifiable risk factor, it is crucial to consider therapeutic options and interventions to prevent or alleviate skin conditions. This review discusses various therapeutic approaches, including melatonin, L-Theanine, Magnesium-L-threonate, Inositol, Cinnamomi cortex, nervous system regulation, and proper sleep hygiene. These therapeutic options have been studied for their impact on sleep, and importantly, several have been evaluated for their utility as adjuncts for treating skin conditions. Overall, the relationship between sleep and skin health is clear, and incorporating sleep-focused therapeutic interventions offers potential to improve both sleep quality and skin health in individuals with a variety of skin conditions.

9 November 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
RPReethi Padmanabhan
Reethi Padmanabhan
CGConnor Gill
Connor Gill
LJLucie Joerg
Lucie Joerg
MMMiriam Motlak
Miriam Motlak
GGGerardo Guilarte
Gerardo Guilarte
SCSonal Choudhary
Sonal Choudhary
Background: Topical peptides have emerged as a promising cosmeceutical for indications ranging from hyperpigmentation to anti‐aging. However, their role in post‐procedural wound healing following aesthetic interventions remains underexplored. Aims: The aim of this study was to systematically evaluate the evidence supporting the use of topical peptide formulations in enhancing post‐procedural wound healing and patient recovery outcomes. Methods: A systematic review was conducted to identify clinical studies evaluating topical peptide application following aesthetic dermatologic procedures, including radiofrequency microneedling and non‐ablative laser therapies. Eligible studies assessed both cosmetic and therapeutic outcomes related to wound healing and recovery. Results: Six studies met inclusion criteria across three peptide systems and across ablative laser, nonablative laser, hybrid laser, and radiofrequency microneedling procedures. Peptide formulations following ablative procedures were associated with improvements in exudation, crusting, and epithelial confluence, whereas nonablative procedures demonstrated reduced erythema and improved patient‐reported recovery outcomes, including enhanced skin appearance and texture. Studies of hybrid fractional resurfacing and radiofrequency microneedling similarly reported improvements in selected early recovery outcomes. Conclusion: Topical peptide formulations show potential as adjunctive therapies for improving post‐procedural recovery following aesthetic dermatologic procedures. However, available evidence is limited by varying procedural modalities, small sample sizes, short follow‐up intervals, and restricted demographic diversity. Larger randomized controlled trials with broader representation across Fitzpatrick skin types are necessary to better define the clinical role of topical peptide cosmeceuticals in post‐procedural wound healing.

7 September 2026 in Acta Astronautica
Verified
Journal Article
Closed access
GGGerardo Guilarte
Gerardo Guilarte
CGConnor Gill
Connor Gill
DLDongwon Lee
Dongwon Lee
LJLucie Joerg
Lucie Joerg
RPReethi Padmanabhan
Reethi Padmanabhan
SCSonal Choudhary
Sonal Choudhary

1 January 2026 in Dermatologic Therapy
Verified
Journal Article
Open access
NANana-Hawwa Abdul-Rahman
Nana-Hawwa Abdul-Rahman
LJLucie Joerg
Lucie Joerg
JWJacqueline D. Wang
Jacqueline D. Wang
SCSonal Choudhary
Sonal Choudhary
Background: Methylsulfonylmethane (MSM) is a biologically active sulfur compound that has been implicated in structural protein synthesis and anti‐inflammatory signaling pathways. We conducted a systematic review to evaluate the efficacy and safety of MSM in skin care products and explore the underlying mechanism of action. Methods: This review followed PRISMA guidelines and was registered on PROSPERO (CRD420251274679). PubMed, Embase, ClinicalTrials.gov, Cochrane Library, and Ovid/MEDLINE were searched from inception through December 23, 2025. Eligible studies evaluated topical or oral MSM for dermatologic conditions in human participants. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool for randomized control trials and the Newcastle–Ottawa Scale for nonrandomized studies. Results: Of the 228 records identified, seven studies ( n = 416) met the inclusion criteria: six randomized controlled trials and one case report, in adults with acne vulgaris, erythematous‐telangiectatic rosacea, nail psoriasis, skin aging, and X‐linked ichthyosis. MSM‐containing interventions (both topical and oral) were associated with statistically significant improvements in clinical severity and skin‐related outcomes, including inflammatory lesion counts, erythema, nail severity scores, and measures of skin hydration, elasticity, firmness, texture, and dermal thickness. Reported adverse events were mild and transient, with no serious adverse events or treatment‐related withdrawals. Conclusions: The most reliable evidence supports oral MSM for photoaging, moderate support for acne, erythematous‐telangiectatic rosacea, and nail psoriasis, and weakest evidence for X‐linked ichthyosis. Importantly, studies lasting up to 24 weeks did not identify any serious safety concerns.